Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Intravenous Umbilical Cord Blood Infusion as Cell Therapy for Children With Autism Spectrum Disorder (ASD): Duke ACT

NCT02847182 is registered in ClinicalTrials.gov with Joanne Kurtzberg, MD as lead sponsor.

NCT NCT02847182
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02847182 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Intravenous Umbilical Cord Blood Infusion as Cell Therapy for Children With Autism Spectrum Disorder (ASD): Duke ACT
Lead sponsor
Joanne Kurtzberg, MD
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2016
Completion date
May 31, 2019
Enrollment
180 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asd, autism, autism spectrum disorder, pdd